The BioInsights Podcast

Modernizing cell therapy manufacturing to reduce vein-to-vein times

David Backer, CEO Curate Biosciences Season 2 Episode 8

Charlotte Barker (Editor, BioInsights) speaks with Curate Biosciences’ CEO David Backer and CTO Tony Ward about the need for CAR-T cell therapy manufacturing to evolve, and how a new cell separation technique could boost efficiency.